SVB Securities Initiates Coverage On CureVac with Outperform Rating, Announces Price Target of $13
Portfolio Pulse from richadhand@benzinga.com
SVB Securities analyst Mani Foroohar initiates coverage on CureVac (NASDAQ:CVAC) with an Outperform rating and a price target of $13.
June 08, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CureVac (NASDAQ:CVAC) receives an Outperform rating and a $13 price target from SVB Securities analyst Mani Foroohar.
SVB Securities initiating coverage on CureVac with an Outperform rating and a price target of $13 indicates a positive outlook for the stock. This news is likely to attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100